Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patients (MTM)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01822171|
Recruitment Status : Terminated (Unable to enroll and study intended patient population.)
First Posted : April 2, 2013
Last Update Posted : May 22, 2013
|Condition or disease||Intervention/treatment||Phase|
|Heart Failure||Other: Discharge medication counseling from a pharmacist Other: Home medication if needed Other: Follow-up visit at Medication Therapy Management clinic||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||1 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Multi-Disciplinary Discharge Counseling and MTM Services After Discharge for Heart Failure Patients|
|Study Start Date :||January 2013|
|Actual Primary Completion Date :||May 2013|
|Actual Study Completion Date :||May 2013|
Experimental: Discharge counseling and MTM follow-up
At the time of hospital discharge the subject will receive:
Other: Discharge medication counseling from a pharmacist
Patient will be educated about proper dosing instructions, potential side effects, and when to recontact the treating physician office.
Other: Home medication if needed
Patient will be provided with medication to take home, when needed.
Other: Follow-up visit at Medication Therapy Management clinic
This comprehensive Medication Therapy Management clinic follow-up visit is scheduled for 7 days post hospital discharge. The approximately 1 hour visit is scheduled with a pharmacist to review current drug therapy and make recommendations, if needed, to improve medication utilization.
- Reduction in hospital readmissions [ Time Frame: 30 day ]The readmission rate for the 50 subjects involved in this study will be compared to an equal number patients retrospectively reviewed from a 2011 patient list and matched for heart failure severity. The primary outcome will based on a comparison of the ratio of patients readmitted to the hospital before the discharge instruction program started and after.
- Patient assessment of home medications knowledge at time of hospital discharge [ Time Frame: 3 days ]Post hospital discharge the subject are asked to rate their knowledge regarding the medication they are taking at home on a scale of 1 to 10. The data obtained in this study will be compared to the same data and patient matched population obtained in 2011.
- Patient satisfaction with comprehensive discharge counseling service. [ Time Frame: 7 Days ]The satisfaction survey consists of five interview questions, where the subject subjectively scores each question on a scale of 1 to 10, developed specifically for this study.
- Number of interventions made at the MTM clinic. [ Time Frame: 7 Days. ]The number of drug related therapy interventions the pharmacist makes during the 7 day follow-up visit will be counted. Interventions may include: identifying: an inappropriate drug, inappropriate dose, duplication of medications, or a missing medication to optimize drug therapy.
- Types of interventions made at the MTM clinic. [ Time Frame: 7 days ]The types of intervention the pharmacist may work on during the 7 day follow-up visit include inappropriate drug, inappropriate dose, duplication of medications, missing medication to optimize drug therapy. Other types of interventions may be revealed during this study.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01822171
|United States, Washington|
|Providence Centralia Hospital|
|Centralia, Washington, United States, 98531|
|Providence St. Peter Hospital|
|Olympia, Washington, United States, 98506|
|Principal Investigator:||Laura Hoekstra, Pharm.D.||Providence St. Peter Hospital|